Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series-Reference-Cited by-同舟云学术

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Published:2018-05 Issue:5 Volume:29 Page:1180-1188
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kommoss S.^ORCID,McConechy M.K.,Kommoss F.,Leung S.,Bunz A.,Magrill J.,Britton H.,Kommoss F.,Grevenkamp F.,Karnezis A.,Yang W.,Lum A.,Krämer B.,Taran F.,Staebler A.,Lax S.,Brucker S.Y.,Huntsman D.G.,Gilks C.B.,McAlpine J.N.,Talhouk. A.

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/5/1180/25083210/mdy058.pdf

Reference28 articles.

1. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up;Colombo;Int J Gynecol Cancer,2016

2. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type;Clarke;J Clin Pathol,2010

3. Poor inter-observer reproducibility in the diagnosis of high-grade endometrial carcinoma;Gilks;Am J Surg Pathol,2012

4. Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens;Guan;Int J Gynecol Cancer,2011

5. Reproducibility of histological cell type in high-grade endometrial carcinoma;Han;Mod Pathol,2013

Cited by 489 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma;Human Pathology;2024-10

2. Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma;Gynecologic Oncology;2024-10

3. Advanced endometrial cancer—The next generation of treatment: A society of gynecologic oncology journal club clinical commentary;Gynecologic Oncology Reports;2024-10

4. Molecular classification improves preoperative risk assessment of endometrial cancer;Gynecologic Oncology;2024-10

5. The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup;Gynecologic Oncology;2024-10